I kappa B kinase complex (IKK)

The I kappa B kinase complex (IKK) is a multi-subunit enzyme complex that serves as a master regulator of NF-κB signaling pathways, which are critical for cell survival, immune defense, inflammation, and proliferation[1][9]. The complex consists of two catalytic subunits, IKKα (CHUK) and IKKβ (IKK2), and a regulatory subunit, IKKγ (NEMO); IKKɛ (IKBKE) is a related kinase with overlapping but distinct functions[1][9][3]. IKK phosphorylates IκB proteins, which normally sequester NF-κB transcription factors in the cytoplasm. Phosphorylation targets IκBs for ubiquitin-mediated degradation, allowing NF-κB to translocate to the nucleus and activate hundreds of genes involved in immunity and inflammation[1][3][9]. Dysregulation of IKK activity is implicated in inflammatory diseases, autoimmune disorders, and many cancers[1][2][9]. As a result, IKK kinases—especially IKKβ—are considered validated therapeutic targets, and several small-molecule kinase inhibitors have been developed and characterized, though clinical application is challenged by risks of systemic immunosuppression and broad physiological impact[2][8][9].

Other names

IkappaB kinaseIκB kinaseNF-kappa-B kinasenuclear factor-kappa B kinaseIBKBIKK complexIKKα (IKK alpha, CHUK)IKKβ (IKK beta, IKK2)IKKγ (IKK gamma, NEMO)IKKɛ (IKK epsilon, IKBKE)inhibitor of nuclear factor kappa-B kinase

Inhibition of IKK leads to blockade of phosphorylation of IκB proteins, thereby preventing NF-κB activation and nuclear translocation Allosteric or ATP-competitive kinase inhibition Interfering with signal transduction cascades that activate NF-κB-dependent gene expression